TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06511141: Sacral Neuromodulation for Male Overactive Bladder

Sponsor: Axonics, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 150 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$12,889,800

Rescue Site Savings

+$8,500,800

Unlock Full NCT06511141 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06511141 Rescue Dossier →